Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Epigenomics (GB:0QXH)
LSE:0QXH
Epigenomics (0QXH) Share Price & Analysis
0 Followers
0QXH Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range€3.80 - €7.15
Previous Close€3.8
Volume0.00
Average Volume (3M)N/A
Market Cap
€279.92K
Enterprise Value-€14.53M
Total Cash (Recent Filing)€15.77M
Total Debt (Recent Filing)€966.00K
Price to Earnings (P/E)-0.2
Beta-0.52
Next Earnings
May 08, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-19.49
Shares Outstanding4,266,429
10 Day Avg. Volume0
30 Day Avg. VolumeN/A
Standard Deviation0.80
R-Squared0.00564
Alpha0.10
Financial Highlights & Ratios
Price to Book (P/B)0.19
Price to Sales (P/S)46.08
Price to Cash Flow (P/CF)-0.30
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
0QXH FAQ
What was Epigenomics’s price range in the past 12 months?
Epigenomics lowest share price was €3.80 and its highest was €7.15 in the past 12 months.
What is Epigenomics’s market cap?
Currently, no data Available
When is Epigenomics’s upcoming earnings report date?
Epigenomics’s upcoming earnings report date is May 08, 2024 which is tomorrow.
How were Epigenomics’s earnings last quarter?
Currently, no data Available
Is Epigenomics overvalued?
According to Wall Street analysts Epigenomics’s price is currently Overvalued.
Does Epigenomics pay dividends?
Epigenomics does not currently pay dividends.
What is Epigenomics’s EPS estimate?
Epigenomics’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Epigenomics have?
Epigenomics has 170,683 shares outstanding.
What happened to Epigenomics’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Epigenomics?
Currently, no hedge funds are holding shares in GB:0QXH
---
Epigenomics Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Company Description
Epigenomics
Epigenomics AG is a molecular diagnostics company, focuses on developing and commercializing in vitro diagnostic liquid biopsy tests for the screening, early detection, and diagnosis of cancer. The company develops and markets procedures and devices for the production in quantity of particular epigenetic parameters such as DNA methylation patterns as well as the information technology bases necessary for their procurement and evaluation. It is engaged in the development of novel molecular diagnostic products for cancer. The company products include Epi proColon, Epi BiSKit, HCCBloodTest, and Epi proLung. The company operates in Europe, North America, Asia, and the Rest of the world.
---
0QXH Stock 12 Months Forecast
Average Price Target
―Technical Analysis
Best Analysts Covering 0QXH
1 Year
1 Year Success Rate
0/2 ratings generated profit
1 Year Average Return
0.00%
reiterated a buy rating 5 months ago
Copying Christian Ehmann's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of 0.00% per trade.
---